drugset / Trial / NCT04989972
Assessing the Efficacy of Micro-dosed Psilocybin on Reducing Anxiety & Depression Levels in Adults
Phase 2
Withdrawn
Wake Network, Inc.
Professor Roger Gibson Section of Psychiatry Faculty of Medical Sciences UWI · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
To investigate the efficacy of a 16 week treatment with PSIL428 patient reported anxiety levels in otherwise healthy individuals suffering from depression and or anxiety symptoms.
Timeline
- Start
- 2022-09-15
- Primary completion
- 2023-06-20
- Completion
- 2023-08-31
Outcome
Outcome not reported
Stopped: “GCP VIOLATIONS FROM THE SPONSORS”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PSIL428 | Unknown | 1 mg | — |